Artia Global Partners LP Kura Oncology, Inc. Transaction History
Artia Global Partners LP
- $498 Billion
- Q1 2024
A detailed history of Artia Global Partners LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 39,478 shares of KURA stock, worth $812,457. This represents 0.17% of its overall portfolio holdings.
Number of Shares
39,478Holding current value
$812,457% of portfolio
0.17%Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
174Shares Held
80.4MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$145 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$120 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$111 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$98.5 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.38B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...